On October 12, 2022, CANARIABIO Inc. closed the transaction. The company issued 1,457,655 shares for gross proceeds of KRW 29,999,997,555.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
412 KRW | +26.77% | -.--% | -64.17% |
2023 | Sejong Medical Co., Ltd.(KOSDAQ:A258830) dropped from S&P Global BMI Index | CI |
2023 | Sejong Medical Co., Ltd. announced that it has received KRW 3.5 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-64.17% | 16.65M | |
+9.33% | 27.43B | |
-29.70% | 3.18B | |
-18.01% | 2.53B | |
+7.75% | 2.49B | |
+11.11% | 2.16B | |
-3.87% | 2.03B | |
+7.22% | 1.61B | |
+30.81% | 1.29B | |
+9.01% | 1.17B |
- Stock Market
- Equities
- A258830 Stock
- News Sejong Medical Co., Ltd.
- CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd.